clinical trial · NCT06782334
AMT-116 in Patients with Solid Tumors
Advanced Solid TumorsAMT-116
brief summary
The purpose of this study is to evaluate the safety and efficacy of AMT-116 monotherapy in subjects with advanced solid tumors. The study is divided into two parts: the part I is dose escalation and the Part Ⅱ for expansion.
started
May 7, 2024
primary completion
Jun 30, 2026
completion
Dec 30, 2026
last updated
Jan 17, 2025
official title
Phase 1/2 Study of AMT-116 in Patients with Advanced Solid Tumors
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol